Skip to main content
TipRanks
Go Ultimate75% OFF

China SXT Pharmaceuticals (SXTC) Stock Statistics & Valuation Metrics

326 Followers

Total Valuation

China SXT Pharmaceuticals has a market cap or net worth of $2.06M. The enterprise value is -$18.25T.

Market Cap
$2.06M
Enterprise Value
-$18.25T

Share Statistics

China SXT Pharmaceuticals has 686,775 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
686,775
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

China SXT Pharmaceuticals’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -23.11%.

Return on Equity (ROE)
-0.21
Return on Assets (ROA)
-0.18
Return on Invested Capital (ROIC)
-23.11%
Return on Capital Employed (ROCE)
-0.23
Revenue Per Employee
19.15K
Profits Per Employee
-110.81K
Employee Count
56
Asset Turnover
0.03
Inventory Turnover
0.30

Valuation Ratios

The current PE Ratio of China SXT Pharmaceuticals is -0.00. China SXT Pharmaceuticals’s PEG ratio is 0.00.

PE Ratio
-0.00
PS Ratio
0.01
PB Ratio
0.00
Price to FCF
-0.00
Price to Operating Cash Flow
-0.00
PEG Ratio
0.00

Income Statement

In the last 12 months, China SXT Pharmaceuticals had revenue of 1.07M and earned -6.21M in profits. Earnings per share was -913.00.

Revenue
1.07M
Gross Profit
183.28K
Operating Income
-7.12M
Pretax Income
-6.07M
Net Income
-6.21M
EBITDA
-6.98M
Earnings Per Share (EPS)
-913.00

Cash Flow

In the last 12 months, operating cash flow was -6.03M and capital expenditures -4, giving a free cash flow of -6.03M billion.

Operating Cash Flow
-6.03M
Free Cash Flow
-6.03M
Free Cash Flow per Share
-1028.71

Dividends & Yields

China SXT Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-37616.65%
Earnings Yield
-35308.32%

Stock Price Statistics

Beta
0.95
52-Week Price Change
-100.00%
50-Day Moving Average
114.34
200-Day Moving Average
9749.88
Relative Strength Index (RSI)
27.90
Average Volume (3m)
233.47K

Financial Position

China SXT Pharmaceuticals as a current ratio of 7.93, with Debt / Equity ratio of 3.77%

Current Ratio
7.93
Quick Ratio
7.25
Debt to Market Cap
0.01
Net Debt to EBITDA
3.88
Interest Coverage Ratio
-113.13

Taxes

In the past 12 months, China SXT Pharmaceuticals has paid 130.84K in taxes.

Income Tax
130.84K
Effective Tax Rate
-0.02

Enterprise Valuation

China SXT Pharmaceuticals EV to EBITDA ratio is 3.87, with an EV/FCF ratio of 4.49.

EV to Sales
-25.21
EV to EBITDA
3.87
EV to Free Cash Flow
4.49
EV to Operating Cash Flow
4.49

Balance Sheet

China SXT Pharmaceuticals has $28.18M in cash and marketable securities with $1.12M in debt, giving a net cash position of $27.06M billion.

Cash & Marketable Securities
$28.18M
Total Debt
$1.12M
Net Cash
$27.06M
Net Cash Per Share
$39.39
Tangible Book Value Per Share
$5,070.18

Margins

Gross margin is 17.09%, with operating margin of -996.09%, and net profit margin of -578.49%.

Gross Margin
17.09%
Operating Margin
-996.09%
Pretax Margin
-566.29%
Net Profit Margin
-578.49%
EBITDA Margin
-650.71%
EBIT Margin
-664.06%

Analyst Forecast

The average price target for China SXT Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
-34.63%
EPS Growth Forecast
97.52%